The performance of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key territories has introduced considerable uncertainty . Investors are now facing the consequences of generic